NLRP3 and prostate cancer: Similarly, Natriuretic peptides such as Atrial Natriuretic Peptides (ANPs) and B-Type Natriuretic Peptide (BNP) have been found to inhibit NLRP3 inflammasome and its associated inflammatory response in prostate cancer [205].